» Articles » PMID: 29479954

Cervical Cancer Prevalence, Incidence and Mortality in Low And Middle Income Countries: A Systematic Review

Overview
Specialty Oncology
Date 2018 Feb 27
PMID 29479954
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cervical cancer rates vary across the world, being highest in Eastern Africa (including Zimbabwe) and lowest in Western Asia. It is the second most common type of cancer in women in the South East Asia region and a major cause of cancer deaths among women of low and middle income countries (LMICs) like Nepal. This review is an attempt to make a comprehensive report of prevalence, incidence and mortality of cervical cancer in LMICs. Methods: The review was conducted applying a computerized search with the Medical Subject Heading (MeSH) major topics “Cervical Cancer”, “Cervical neoplasm” “Epidemiology”, (“prevalence” OR “incidence” OR “mortality”) and “HPV” OR “Human papillomavirus” as MeSH subheading. The search limits were: language (“English”), LMICs, dates (articles published from “1st January 2000 to 31st December 2015”), and species (“Humans”). The search was supplemented by cross-referencing. Publications that met the inclusion criteria were included in the synthesis. Results: Among the 20 studies reviewed; seven were from Africa, seven from Asia, three from South America, and one each from North America, Europe and Oceania. The review found the highest reported age standardized incidence rate as 17.9/100,000/year in Zimbabwe in 2000 and the lowest as 0.11/100,000/year in China in 2006. One study of Nigeria revealed a cervical cancer prevalence of 5.0 per 1,000 in 2012 in the 25-64 year age group. Further, the highest reported age standardized mortality rate was 16/100,000/year in India in 2015 and the lowest 1.8/100,000/year in Colombia in 2013. In addition, coitarche, tobacco smoking, number of sexual partners and family history of cervical cancer were reported as significant risk factors. Conclusion: The study provides a review of reported prevalence, incidence and mortality of cervical cancer in LMICs from 1st January 2000 to 31st December 2015. The scarcity of information reveals a substantial need for further studies on cervical cancer prevalence, incidence and mortality with associated risk factors in LMICs.

Citing Articles

Advances in human papillomavirus detection for cervical cancer screening and diagnosis: challenges of conventional methods and opportunities for emergent tools.

Fashedemi O, Ozoemena O, Peteni S, Haruna A, Shai L, Chen A Anal Methods. 2025; 17(7):1428-1450.

PMID: 39775553 PMC: 11706323. DOI: 10.1039/d4ay01921k.


Cervical intraepithelial neoplasia and cervical cancer in Hunan Province, China, 2020-2023.

Zhou X, Han T, Guo T, Liu Y, Li H, Yingxia W Front Oncol. 2024; 14:1480983.

PMID: 39697223 PMC: 11652369. DOI: 10.3389/fonc.2024.1480983.


Human umbilical cord mesenchymal stem cells derived-exosomes alleviate LPS-induced cervical inflammation and epithelial-mesenchymal transition.

Yi C, Wang H, Azhar Ud Din M, Xia Y, Akanyibah F, Mao F Am J Transl Res. 2024; 16(11):6903-6913.

PMID: 39678571 PMC: 11645556. DOI: 10.62347/PKYU4876.


Exploring the Clinical Signatures of Cervical Dysplasia Patients and Their Association With Vaginal Microbiota.

Cheng L, Yan C, Yang Y, Hong F, Du J Cancer Med. 2024; 13(23):e70440.

PMID: 39641435 PMC: 11622153. DOI: 10.1002/cam4.70440.


The lower incidence of cervical cancer in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors utilization.

Tsui T, Ho Y, Ueng K, Liao P, Huang J, Lee C J Cancer. 2024; 15(19):6196-6203.

PMID: 39513110 PMC: 11540508. DOI: 10.7150/jca.101165.


References
1.
Munoz N, Bosch F, Castellsague X, Diaz M, de Sanjose S, Hammouda D . Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004; 111(2):278-85. DOI: 10.1002/ijc.20244. View

2.
Wang T, Wu M, Wu Y, Zhang W . A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008. Chin Med J (Engl). 2015; 128(24):3298-304. PMC: 4797504. DOI: 10.4103/0366-6999.171420. View

3.
Kuehn R, Fong J, Taylor R, Gyaneshwar R, Carter K . Cervical cancer incidence and mortality in Fiji 2003-2009. Aust N Z J Obstet Gynaecol. 2012; 52(4):380-6. DOI: 10.1111/j.1479-828X.2012.01461.x. View

4.
Sankaranarayanan R, Nene B, Shastri S, Jayant K, Muwonge R, Budukh A . HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-94. DOI: 10.1056/NEJMoa0808516. View

5.
Kalakun L, Bozzetti M . Evolution of uterine cervical cancer mortality from 1979 to 1998 in the State of Rio Grande do Sul, Brazil. Cad Saude Publica. 2005; 21(1):299-309. DOI: 10.1590/s0102-311x2005000100033. View